The occurrence of refractoriness and mast cell mediator release following mannitol-induced bronchoconstriction

Journal of Applied Physiology

Volumn 110, Issue 4, 2011, Pages 1029-1035

  Larsson, Johan ^a,b   Perry, Clare P ^c   Anderson, Sandra D ^c   Brannan, John D ^c   Dahlén, Sven Erik ^a   Dahlén, Barbro ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Exercise; Leukotrienes; Mast cell activation; Prostaglandins; Tachyphylaxis

Indexed keywords

LEUKOTRIENE E4; MANNITOL; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; DRUG EFFECT; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; MALE; MAST CELL; PATHOPHYSIOLOGY; URINE;

ADMINISTRATION, INHALATION; ADULT; ASTHMA; BRONCHOCONSTRICTION; DINOPROST; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOTRIENE E4; MALE; MANNITOL; MAST CELLS;

EID: 79954571050     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00978.2010     Document Type: Article

References (35)

1. Anderson SD. Is there a unifying hypothesis for exercise-induced asthma? J Allergy Clin Immunol 73: 660-665, 1984. (Pubitemid 14102153)
2. Anderson SD, Silverman M, Konig P, Godfrey S. Exercise-induced asthma. A review. Br J Dis Chest 69: 1-39, 1975.
3. Belcher NG, Murdoch R, Dalton N, Clark TJH, Rees PJ, Lee TH. Circulating concentrations of histamine, neutrophil chemotactic activity, and catecholamines during the refractory period in exercise-induced asthma. J Allergy Clin Immunol 81: 100-110, 1988. (Pubitemid 18057604)
4. Brannan JD, Anderson SD, Gomes K, King GG, Chan HK, Seale JP. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. Am J Respir Crit Care Med 163: 1420-1425, 2001. (Pubitemid 32506610)
5. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 22: 491-496, 2003. (Pubitemid 37098931)
6. Brannan JD, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J 27: 944-950, 2006. (Pubitemid 44911107)
7. Cabral ALB, Concei̧ão GM, Fonseca-Guedes CHF, Martins MA. Exercise-induced bronchospasm in children. Am J Respir Crit Care Med 159: 1819-1823, 1999.
8. Currie GP, Haggart K, Lee DKC, Fowler SJ, Wilson AM, Brannan JD, Anderson SD, Lipworth BJ. Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clin Exp Allergy 33: 783-788, 2003. (Pubitemid 36760510)
9. Dahlén B, Roquet A, Inman MD, Karlsson Ö, Naya I, Anstrén G, O'Byrne PM, Dahlén SE. Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. J Allergy Clin Immunol 109: 789-793, 2002.
10. Dahlén SE. The significance of liberated cyclooxygenase products for the pulmonary and cardiovascular actions of leukotriene C4 in the guinea pig depends upon the route of administration. Acta Physiol Scand 118: 415-421, 1983. (Pubitemid 13049033)
11. Dahlén SE, Kumlin M. Monitoring mast cell activation by prostaglandin D2 in vivo. Thorax 59: 453-455, 2004. (Pubitemid 38797513)
12. Edmunds A, Tooley M, Godfrey S. The refractory period after exerciseinduced asthma: Its duration and relation to the severity of exercise. Am Rev Respir Dis 117: 247-254, 1978. (Pubitemid 8319021)
13. Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M. Release of prostaglandin D2 and leukotriene C in response to hyperosmolar stimulation of mast cells. Allergy 61: 1473-1479, 2006. (Pubitemid 44665314)
14. Hawksworth RJ, O'Hickey SP, Lee TH. The effects of indomethacin on the refractory period to hypertonic saline-induced bronchoconstriction. Eur Respir J 5: 963-966, 1992.
15. Johnson M. The beta-adrenoceptor. Am J Respir Crit Care Med 158: 146-153, 1998.
16. Kay LJ, Yeo WW, Peachell PT. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br J Pharmacol 147: 707-713, 2006.
17. Kern R, Smith LJ, Patterson R, Krell RD, Bernstein PR. Characterization of the airway response to inhaled leukotriene D4 in normal subjects. Am Rev Respir Dis 133: 1127-1132, 1986. (Pubitemid 16090025)
18. Kippelen P, Larsson J, Anderson SD, Brannan JD, Dahlen B, Dahlen SE. Effect of sodium cromoglycate on mast cell mediators during hyperpnea in athletes. Med Sci Sports Exerc 42: 1853-1860, 2010.
19. Kippelen P, Larsson J, Anderson SD, Brannan JD, Delin I, Dahlen B, Dahlen SE. Acute effects of beclomethasone on hyperpnoea-induced bronchoconstriction. Med Sci Sports Exerc 42: 273-280, 2010.
20. Kumlin M, Stensvad F, Larsson L, Dahlén B, Dahlén SE. Validation and application of a new simple strategy for measurements of leukotriene E4 in human urine. Clin Exp Allergy 25: 467-479, 1995.
21. Manning PJ, Watson RM, Margolskee DJ, Williams VC, Schwartz JI, O'Byrne PM. Inhibition of exercise-induced bronchoconstriction by MK- 571, a potent leukotriene D4-receptor antagonist. N Engl J Med 323: 1736-1739, 1990.
22. Manning PJ, Watson RM, O'Byrne PM. Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms. Am Rev Respir Dis 148: 950-954, 1993. (Pubitemid 23301212)
23. Margolskee DJ, Bigby BG, Boushey HA. Indomethacin blocks airway tolerance to repetitive exercise but not to eucapnic hyperpnea in asthmatic subjects. Am Rev Respir Dis 137: 842-846, 1988. (Pubitemid 18099296)
24. McFadden ER, Lenner KA, Strohl KP. Postexertional airway rewarming and thermally induced asthma. J Clin Invest 78: 18-25, 1986.
25. Melillo E, Woolley KL, Manning PJ, Watson RM, O'Byrne PM. Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 149: 1138-1141, 1994. (Pubitemid 24147051)
26. Morton NE, Collins AN. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci USA 95: 11389-11393, 1998. (Pubitemid 28450138)
27. O'Byrne PM, Jones GL. The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. Am Rev Respir Dis 134: 69-72, 1986. (Pubitemid 16057462)
28. O'Hickey SP, Arm JP, Rees PJ, Lee TH. Airway responsiveness to methacholine after inhalation of nebulized hypertonic saline in bronchial asthma. J Allergy Clin Immunol 83: 472-476, 1989. (Pubitemid 19079744)
29. Omini C, Folco GC, Viganó T, Rossoni G, Brunelli G, Berti F. Leukotriene-C4 induces generation of PGI2 and TXA2 in guinea-pig in vivo. Pharmacol Res Commun 13: 633-640, 1981. (Pubitemid 12226218)
30. O'Sullivan Kumlin M, Dahlén B, Dahlén SE. Increased urinary excretion of the prostaglandin D2 metabolite 9a,11b-prostaglandin F2 following aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 98: 421-432, 1996.
31. O'Sullivan S, Roquet A, Dahlén B, Larsen F, Eklund A, Kumlin M, O'Byrne PM, Dahlén SE. Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J 12: 345-350, 1998. (Pubitemid 28389527)
32. Rakotosihanaka F, Melamam F, d'Athis P, Florentin D, Dessanges JF, Lockhart A. Refractoriness after hyperventilation-induced asthma. Bull Eur Physiopath Respir 22: 581-587, 1986. (Pubitemid 17014557)
33. Schoeffel RE, Anderson SD, Gillam I, Lindsay DA. Multiple exercise and histamine challenge in asthmatic patients. Thorax 35: 164-170, 1980. (Pubitemid 10131194)
34. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotrienereceptor expression on nasal mucosal inflammatory cells in aspirinsensitive rhinosinusitis. N Engl J Med 347: 1493-1499, 2002. (Pubitemid 35257588)
35. Tullett WM, Tan KM, Wall RT, Patel KR. Dose-response effect of sodium cromoglycate pressurised aerosol in exercise induced asthma. Thorax 40: 41-44, 1985. (Pubitemid 15110830)